We believe access to medicine should be global by design.
Too often, patients are held back by practical barriers, fragmented supply chains or unfamiliarity with complex regulatory routes. These challenges delay access to critical, life-saving treatments, particularly in less well-served markets.
Our purpose is to help remove those barriers.
As pathfinders, we navigate complexity and support access to medicines across the product lifecycle, from clinical trials and early access programs through to long-term commercialisation, using both licensed and unlicensed pathways.
We work in close partnership with pharmaceutical and biotechnology companies, guiding them through practical, regulatory and geographical challenges with experience, judgement and collaboration.
By combining global reach with strong local insight, our teams work together to deliver access where it matters most.
Whatever the challenge, we find a way.
Lifecycle services
Each step in a product’s lifecycle brings challenges that could make or break it.
You’ve put all your energies into getting it this far. Now you need a partner to help you make the most of your asset.
A partner alongside you as you reach your strategic milestones and regulatory hurdles.
A partner who can help you with safety and handle inquiries and calls to ease your operational burden and forge a lasting relationship.
Find out why we are your perfect partner.
Clinical Services
Clinical development is getting more complex and harder to manage.
Innovators are overburdened. Missteps lead to expensive delays.
Too many outsource partners lack the experience to really help. Or they are built for a different generation of therapies, when scale and automation was enough.
We are pathfinders for innovative medicines - offering genuine expertise, designed for agility and delivering industry best cycle times.
Product access and commercialisation
Disease doesn’t wait. And it doesn’t care where you live.
We believe that access to medicine should be global by design, whether pre-approval, commercially available or long-term unlicensed.
Work with us to make sure your access plans truly meet patient demand.